Chloe Brown, Ceroflo – SubMax™ Intracranial Stent | LSI Asia '25

Ceroflo Limited, based in Galway, Ireland, is developing an innovative solution for the treatment and prevention of stroke, one of the world’s leading causes of death and disability. The company’s proprietary device, the SubMax™ Stent, is specifically designed to address intracranial atherosclerosis (ICAD)—a major contributor to stroke, particularly in Asia, where it accounts for up to 50% of cases. SubMax™ gently restores blood flow to the brain while minimizing the risks associated with earlier-generation devices.